You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GS-9973

Showing 1 - 25 of 279
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Previously Untreated Acute Myeloid Leukemia Trial in United States (biological, other, drug)

Recruiting
  • Previously Untreated Acute Myeloid Leukemia
  • Samalizumab (BAML-16-001-S1)
  • +32 more
  • Phoenix, Arizona
  • +18 more
Oct 17, 2022

Anemia, B-Cell Prolymphocytic Leukemia, Grade 1 Follicular Lymphoma Trial in Portland (drug, other, biological)

Completed
  • Anemia
  • +13 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Apr 29, 2021

Chronic Lymphocytic Leukemia Trial in Germany (Tirabrutinib, Entospletinib, Obinutuzumab)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Aschaffenburg, Germany
  • +14 more
Dec 17, 2021

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in United States (Entospletinib,

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • +3 more
  • La Jolla, California
  • +12 more
May 18, 2020

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in Canada, United States (Entospletinib

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Entospletinib MM
  • Entospletinib SDD
  • Birmingham, Alabama
  • +47 more
Nov 2, 2020

Acute Lymphoblastic Leukemia Trial in Canada, Germany, United States (Entospletinib, Vincristine, Dexamethasone)

Terminated
Has Results
  • Acute Lymphoblastic Leukemia
  • Duarte, California
  • +12 more
Dec 23, 2019

Nucleophosmin 1-mutated Acute Myeloid Leukemia Trial in Worldwide (Entospletinib, Placebo, Cytarabine)

Recruiting
  • Nucleophosmin 1-mutated Acute Myeloid Leukemia
  • Duarte, California
  • +60 more
Jul 20, 2022

Hematologic Malignancy, Acute Myeloid Leukemia Trial in Japan (Entospletinib, Daunorubicin, Cytarabine)

Terminated
Has Results
  • Hematologic Malignancy
  • Acute Myeloid Leukemia
  • Fukui, Japan
  • +5 more
Feb 21, 2020

Acute Myeloid Leukemia Trial in Canada, Germany, United States (Entospletinib, Daunorubicin, Cytarabine)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +16 more
Nov 13, 2019

Non-Hodgkin Lymphoma Trial in France, United States (Entospletinib, Vincristine)

Terminated
Has Results
  • Non-Hodgkin Lymphoma
  • Hattiesburg, Mississippi
  • +6 more
Mar 26, 2019

Oncology Trial in Germany, New Zealand, United States (Entospletinib)

Completed
Has Results
  • Oncology
  • Miami, Florida
  • +5 more
May 24, 2019

Rheumatoid Arthritis, Systemic Lupus Erythematosus Trial (GS-0272, Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • (no location specified)
Sep 4, 2023

Alcohol Consumption Trial in Palo Alto (Control, Goal Support (GS), Coaching for Context-specific Peer Support (CCPS))

Enrolling by invitation
  • Alcohol Consumption
  • Control
  • +2 more
  • Palo Alto, California
    Stanford University
May 8, 2023

Chronic Hepatitis B Trial (GS-2829, GS-6779, Placebo for GS-2829)

Not yet recruiting
  • Chronic Hepatitis B
  • GS-2829
  • +3 more
  • (no location specified)
Mar 14, 2023

Genetic Predisposition Trial in Tübingen (Next-Generation Sequencing (NGS))

Not yet recruiting
  • Genetic Predisposition
  • Next-Generation Sequencing (NGS)
  • Tübingen, Germany
    University Hospital Tübingen
Sep 22, 2023

Gastroschisis Trial in Houston (fetoscopy)

Recruiting
  • Gastroschisis
  • fetoscopy
  • Houston, Texas
    Texas Children's Hospital
Jan 20, 2023

HIV Trial (Teropavimab, Zinlirvimab, Lenacapavir Tablet)

Not yet recruiting
  • HIV Infections
  • Teropavimab
  • +4 more
  • (no location specified)
Feb 6, 2023

Solid Tumors Trial (GS-9911, Zimberelimab)

Not yet recruiting
  • Solid Tumors
  • (no location specified)
Oct 9, 2023

Solid Tumor Trial (GS-4528, Zimberelimab)

Not yet recruiting
  • Solid Tumor
  • (no location specified)
Apr 21, 2023

STEMI - ST Elevation Myocardial Infarction Trial

Not yet recruiting
  • STEMI - ST Elevation Myocardial Infarction
    • (no location specified)
    Dec 24, 2022

    HIV-1 Infection Trial in United States (Oral Lenacapavir, Subcutaneous Lenacapavir, Teropavimab)

    Active, not recruiting
    • HIV-1 Infection
    • Oral Lenacapavir
    • +3 more
    • Los Angeles, California
    • +22 more
    Nov 4, 2022

    COVID-19 Trial (GS-5245, GS-5245 Placebo)

    Not yet recruiting
    • COVID-19
    • (no location specified)
    Feb 3, 2023

    COVID-19 Trial in Canada, Poland, Romania (GS-5245, GS-5245 Placebo)

    Recruiting
    • COVID-19
    • Hamilton, Canada
    • +8 more
    Jan 24, 2023

    HIV-1-infection Trial in United States (GS-5894, B/F/TAF, Standard of Care)

    Recruiting
    • HIV-1-infection
    • Los Angeles, California
    • +15 more
    Jan 13, 2023

    Advanced Solid Tumors Trial in United States (GS-3583)

    Active, not recruiting
    • Advanced Solid Tumors
    • Grand Rapids, Michigan
    • +3 more
    Jul 22, 2022